A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting

Completed · Phase 2

Conditions studied: Postoperative Nausea and Vomiting, Nausea and Vomiting, Postoperative

In brief

This study is looking at a range of doses of this NK-1 receptor antagonist drug, for both safety and effectiveness in prevention PONV

Key facts

Study ID

NCT00108095

Run by

GlaxoSmithKline

People needed

701

Starts

2004-10-01

Expected to finish

2005-08-01

Last updated by the study team

2017-01-20

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females age 18-55
• Laparoscopic/laparotomic gynecological procedure of laparoscopic gallbladder removal

You may not qualify if…

• Pregnant or breastfeeding
• Post-menopausal
• Not undergoing general anesthesia

Where it is running

• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Arcadia, California, United States
• GSK Investigational Site — Duarte, California, United States
• GSK Investigational Site — Glendale, California, United States
• GSK Investigational Site — Laguna Hills, California, United States
• GSK Investigational Site — Loma Linda, California, United States
• GSK Investigational Site — Pasadena, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — Stanford, California, United States
• GSK Investigational Site — Naples, Florida, United States
• GSK Investigational Site — Pensacola, Florida, United States
• GSK Investigational Site — Alpharetta, Georgia, United States
• GSK Investigational Site — Hutchinson, Kansas, United States
• GSK Investigational Site — Kansas City, Kansas, United States
• GSK Investigational Site — Baton Rouge, Louisiana, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — Jackson, Mississippi, United States
• GSK Investigational Site — New Brunswick, New Jersey, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — Winston-Salem, North Carolina, United States
• GSK Investigational Site — Pittsburgh, Pennsylvania, United States
• GSK Investigational Site — Charleston, South Carolina, United States
• GSK Investigational Site — Houston, Texas, United States
• GSK Investigational Site — Montgomery, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.